We could not find any results for:
Make sure your spelling is correct or try broadening your search.
| Ticker | Name | Price | Change | Change % | Volume | Trades |
|---|---|---|---|---|---|---|
1AIN | Algorae Pharmaceuticals Limited | 0.00 | 0.00 | 0.00% | 0.00 | 0 |
1CG | One Click Group Limited | 0.0095 | 0.00 | 0.00% | 0.00 | 0 |
1CGO | One Click Group Ltd | 0.001 | 0.00 | 0.00% | 0.00 | 0 |
1MC | Morella Corporation Ltd | 0.026 | 0.00 | 0.00% | 0.00 | 0 |
1AI | Algorae Pharmaceuticals Limited | 0.013 | 0.00 | 0.00% | 0.00 | 0 |
1AE | Aurora Energy Metals Ltd | 0.07 | 0.00 | 0.00% | 0.00 | 0 |
14D | 1414 Degrees Limited | 0.02 | 0.00 | 0.00% | 0.00 | 0 |
14DOA | 1414 Degrees Limited | 0.004 | 0.00 | 0.00% | 0.00 | 0 |
1AD | AdAlta Limited | 0.004 | 0.00 | 0.00% | 0.00 | 0 |
1ADO | AdAlta Limited | 0.0025 | 0.00 | 0.00% | 0.00 | 0 |
10X | Exulant Mining Ltd | 0.175 | 0.00 | 0.00% | 0.00 | 0 |
Statistically Significant Reduction in Srebf1 (Fat Production) and Increased Pparα (Fat Metabolism) Position GDNF as Next-Generation Therapy for MAFLD and ObesityNEW YORK, April 13, 2026 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company, today announced positive data from its HT-VA study, conducted under its Cooperative Research and Development Agreement (CRADA) with the U.S. Department of Veterans Affairs and Emory University, demonstrating that parenteral GDNF (Glial Cell-Derived Neurotrophic Factor) directly reprograms liver fat metabolism at the genetic level in a preclinical model of metabolic-associated fatty liver disease (MAFLD).
Effort Underscores GoPro's Commitment to Expanding its Technology into Specialized, High-Demand SectorsSAN MATEO, Calif., April 13, 2026 /PRNewswire/ -- GoPro, Inc. (NASDAQ: GPRO) today announced that it will pursue new market opportunities for its technology within the defense and aerospace sector. It has engaged Oliver Wyman, a global leader in management consulting and a business of Marsh, for this work.
Momentus Inc. (NASDAQ: MNTS) (“Momentus” or the “Company”), a U.S. commercial space company specializing in satellite technology, space transportation, and in-orbit services, today shared a series of significant achievements in the ongoing Vigoride-7 mission, marking one of the most successful early-phase operations in the company’s history.
Credo Technology Group Holding Ltd (Credo) (NASDAQ: CRDO), an innovator in providing secure, high-speed connectivity solutions that deliver improved reliability and energy efficiency for the next generation of AI-driven applications, cloud computing, and hyperscale networks, today announced it has entered into a definitive agreement to acquire DustPhotonics, a leading developer of Silicon Photonics Photonic Integrated Circuit (SiPho PIC) technology for optical transceivers. The acquisition will position Credo with a vertically integrated connectivity stack spanning SerDes, Digital Signal Processing (DSP), Silicon Photonics and system integration for scale out and scale up networks — addressing both electrical and optical interconnects across the ...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions